BioXcel Therapeutics, Inc. (BTAIQ): Shareholders' Equity
-$95.46M
As of 2025-12-31
-$115.46M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$95.46M | n/m | 2026-03-27, Balance as of period end |
| 2024-12-31 | -$93.10M | n/m | 2026-03-27, Balance as of period end |
| 2023-12-31 | -$56.51M | n/m | 2025-03-28, Balance as of period end |
| 2022-12-31 | $76.78M | -65.4% | 2024-03-22, Balance as of period end |
| 2021-12-31 | $221.67M | +7.2% | 2023-03-16, Balance as of period end |
| 2020-12-31 | $206.70M | +668.5% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $26.89M | -30.8% | 2021-03-12, Balance as of period end |
| 2018-12-31 | $38.89M | n/m | 2020-03-09, Balance as of period end |
| 2017-12-31 | -$982.0K | n/a | 2019-03-12, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | -$95.46M | n/m |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | -$1.22M | n/m |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | -$2.49M | n/m |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $7.84M | +17.7% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $2.99M | -62.8% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $27.77M | -46.7% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $62.30M | -53.5% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $641.6K | -89.3% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $1.92M | -39.0% |
Compare BTAIQ, PMHS, VCNX, ELAB side by side · Screen every company in Pharmaceutical Preparations ↗